Paeoniflorin inhibits macrophage-mediated lung cancer metastasis

被引:28
|
作者
Wu Qi [1 ]
Chen Gang-Ling [2 ]
Li Ya-Juan [3 ]
Chen Yang [2 ]
Lin Fang-Zhen [2 ]
机构
[1] China Pharmaceut Univ, Res Dept Pharmacognosy, State Key Lab Nat Med, Nanjing 211198, Jiangsu, Peoples R China
[2] China Pharmaceut Univ, Dept Pharm Chinese Mat Med, Nanjing 211198, Jiangsu, Peoples R China
[3] Shanghai Univ Tradit Chinese Med, Murad Res Inst Modernized Chinese Med, Shanghai 201203, Peoples R China
基金
中国国家自然科学基金;
关键词
Paeoniflorin; Lung cancer; Metastasis; Alternatively activated macrophages; Tumor-associated macrophages; TUMOR; LYMPHANGIOGENESIS; ACTIVATION;
D O I
10.1016/S1875-5364(15)30098-4
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Alternatively activated macrophages are more frequently involved in tumor growth, angiogenesis, and immunosuppression. A previous study showed that paeoniflorin, the major active constituent of Paeonia lactiflora Pallas, can inhibit tumor growth and lung metastases of Lewis lung tumor-bearing mice. This study tried to investigate whether paeoniflorin inhibited lung cancer metastasis by inhibiting the alternative activation of macrophages (M2 macrophage). Using a viability assay, the cytotoxicity of paeoniflorin on Lewis lung cancer cells and peritoneal macrophages were investigated. In vitro scratch wound and in vivo lung metastasis experiments were used to test the ability to inhibit the migration of paeoniflorin and the function of M2 macrophages. Flow cytometry was performed to test the cell cycle of Lewis lung cancer cells, and to test the M2 macrophages in peritoneal macrophages and subcutaneous transplantable tumor. It was found that paeoniflorin showed no inhibitory effect on the growth of Lewis lung cancer cells and peritoneal macrophages of mouse in vitro. Paeoniflorin could attenuate the migration of LLC stimulated by alternatively activated macrophages (stimulated for 24 h and 48 h, paeoniflorin 1, 3, 10, 30, 100 mu mol.L-1, P < 0.01 or P < 0.05 vs control group). Paeoniflorin could decrease the cell populations at S phases (paeoniflorin 10, 30, 100 mu mol.L-1, P < 0.05 vs control group) and increase the cell populations at G0-G1 phases of Lewis lung cancer cells (paeoniflorin 100 mu mol.L-1, P < 0.05 vs control group) and reduce the numbers of M2 macrophages in peritoneal macrophages induced by]L-4 (paeoniflorin 1, 3, 10, 30, 100 mu mol.L-1, P < 0.01 vs Control group). Paeoniflorin could reduce lung metastasis of Lewis lung cancer cells xenograft and decrease the numbers of M2 macrophages in subcutaneous xenograft tumour in vivo (paeoniflorin 20, 40 mg.kg(-1), P < 0.01 vs control group). These results suggest that paeoniflorin could reduce lung metastasis of Lewis lung cancer cells xenograft partly through inhibiting the alternative activation of macrophages.
引用
收藏
页码:925 / 932
页数:8
相关论文
共 50 条
  • [1] Paeoniflorin inhibits macrophage-mediated lung cancer metastasis
    WU Qi
    CHEN Gang-Ling
    LI Ya-Juan
    CHEN Yang
    LIN Fang-Zhen
    Chinese Journal of Natural Medicines, 2015, 13 (12) : 925 - 932
  • [2] Emerging nanomedicines for macrophage-mediated cancer therapy
    Shi, Xueying
    Rizvi, Syed Faheem Askari
    Yang, Yinxian
    Liu, Gang
    BIOMATERIALS, 2025, 316
  • [3] Macrophage-mediated cancer drug delivery
    Wang, H. -F.
    Liu, Y.
    Yang, G.
    Zhao, C. -X.
    MATERIALS TODAY SUSTAINABILITY, 2021, 11-12
  • [4] Dihydroartemisinin inhibits lung cancer bone metastasis by modulating macrophage polarization
    Hang, Guihua
    Gu, Xia
    Gu, Yuanyuan
    Gan, Ping
    Hua, Chunwang
    Chen, Aiming
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2025, 30 (01)
  • [5] Harnessing the innate immune system by revolutionizing macrophage-mediated cancer immunotherapy
    Reghu, Gayatri
    Vemula, Praveen Kumar
    Bhat, Sarita Ganapathy
    Narayanan, Sreeja
    JOURNAL OF BIOSCIENCES, 2024, 49 (02)
  • [6] CD47 in Osteosarcoma: Correlation with Metastasis and Macrophage-Mediated Phagocytosis
    Ko, Yunmi
    Park, Seog-Yun
    Park, Jong Woong
    Kim, June Hyuk
    Kang, Hyun Guy
    Lee, Jun Ah
    CELLS, 2024, 13 (22)
  • [7] Targeting Tumor Microenvironment: Effects of Chinese Herbal Formulae on Macrophage-Mediated Lung Cancer in Mice
    Xu, Fei
    Cui, Wenqiang
    Zhao, Zhengxiao
    Gong, Weiyi
    Wei, Ying
    Liu, Jiaqi
    Li, Mihui
    Li, Qiuping
    Yan, Chen
    Qiu, Jian
    Liu, Baojun
    Dong, Jingcheng
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2017, 2017
  • [8] Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling
    Xu, Fei
    Cui, Wen-Qiang
    Wei, Ying
    Cui, Jie
    Qiu, Jian
    Hu, Ling-Li
    Gong, Wei-Yi
    Dong, Jing-Cheng
    Liu, Bao-Jun
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018, 37
  • [9] Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling
    Fei Xu
    Wen-Qiang Cui
    Ying Wei
    Jie Cui
    Jian Qiu
    Ling-Li Hu
    Wei-Yi Gong
    Jing-Cheng Dong
    Bao-Jun Liu
    Journal of Experimental & Clinical Cancer Research, 37
  • [10] Sorafenib inhibits macrophage-mediated epithelial-mesenchymal transition in hepatocellular carcinoma
    Deng, Yan-Ru
    Liu, Wen-Bin
    Lian, Zhe-Xiong
    Li, Xingsheng
    Hou, Xin
    ONCOTARGET, 2016, 7 (25) : 38292 - 38305